TYPFF yields 1333.33% · PFE yields 6.13%● Live data
📍 TYPFF pulled ahead of the other in Year 1
Combined, TYPFF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of TYPFF + PFE for your $10,000?
Goldflare Exploration Inc. acquires, explores for, and develops gold properties in Canada. The company holds 100% interests in the Aiguebelle-Goldfields property consisting of 6 mining claims and covering an area of 253.85 hectares located in the Abitibi-Temiscamingue region; the Syenite Condor property consisting of 20 mining claims and covering an area of 653.12 hectares located in the Clericy Township; the Ranger property consisting of 39 mining claims and covering an area of 1,052.47 hectares located in the Clericy Township; the Windfall property consisting of 28 mining claims and covering an area of 1,145.62 hectares located in the Belmont Township; the Duplessis-Agar property consisting of 10 mining claims and covering an area of approximately 560 hectares located in the Duplessis region; and Duplessis-Mountain property consisting of 6 mining claims and covering an area of approximately 340 hectares located in the Urban-Barry mining camp. It holds 50% interest in the Destorbelle property consisting of 24 mining claims and covering an area of 950.47 hectares located in the Aiguebelle and Destor townships. The company was formerly known as Typhoon Exploration Inc. and changed its name to Goldflare Exploration Inc. in September 2021. Goldflare Exploration Inc. was founded in 2003 and is headquartered in Piedmont, Canada.
Full TYPFF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.